J9263 HCPCS Level II code: Injection, oxaliplatin, 0.5 mg
J9263 is the HCPCS code for “Injection, oxaliplatin, 0.5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9263Injection, oxaliplatin, 0.5 mg
Short description: Oxaliplatin
HCPCS · United States
Medicare details
The indicators CMS publishes with J9263 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2004
Where J9263 sits
- 1J codesDrugs administered other than orally
- 2Active code J9263Injection, oxaliplatin, 0.5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9263 mean?
J9263 is the HCPCS code for “Injection, oxaliplatin, 0.5 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9263?
CMS lists J9263’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9263
All J codesJ9256Injection, nipocalimab-aahu, 3 mgJ9258Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mgJ9259Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mgJ9260Injection, methotrexate sodium, 50 mgJ9261Injection, nelarabine, 50 mgJ9262Injection, omacetaxine mepesuccinate, 0.01 mgJ9264Injection, paclitaxel protein-bound particles, 1 mgJ9265Injection, paclitaxel, 30 mgJ9266Injection, pegaspargase, per single dose vialJ9267Injection, paclitaxel, 1 mgJ9268Injection, pentostatin, 10 mgJ9269Injection, tagraxofusp-erzs, 10 micrograms